According to this research, the global growth of the patented nervous system drugs is slowing down. The drugs used to treat cranial nerve and cerebral circulation systems are experiencing a market downturn. However, the market performance is quite different in China. In recent years, the drug demand from the neurology departments of Chinese hospitals is growing continuously with the rapid development of the pathogenesis of common neurological diseases and clinical pharmacology. Deproteinized Calf Blood Extractives is a big variety and a pillar nervous system drug in clinical applications in China.
The sales value of Deproteinized Calf Blood Extractives reached CNY146.45 million in 2019, the CAGR was -24.7% in 2015 to 2019. In recent years, the main reason for the decline in sales of Deproteinized Calf Blood Extractives in the Chinese market is the continuous decline in sales of injections, and the sales of other dosage forms have an upward trend. The market was dominated by Shenyang Xingqi Pharmaceutical Co., Ltd., Harbin Sanctity Pharmaceutical Co., Ltd., Jilin Connell Pharmaceutical Co., Ltd., Wuhan Humanwell Pharmaceutical Co., Ltd., etc., with CR5 reaching over 90%. Shenyang Xingqi Pharmaceutical Co., Ltd. captured the biggest market share, whose market share exceeded 28.2% by sales value in 2019.
The sales of Deproteinized Calf Blood Extractives injections in the Chinese market are showing a declining trend, but the sales of other dosage forms, such as gels, are rising rapidly. It is expected that the overall sales of Deproteinized Calf Blood Extractives in China may rebound in the next few years.
Topics Covered:
- Development environment of the Chinese Deproteinized Calf Blood Extractives market
- Market Size of the Chinese Deproteinized Calf Blood Extractives market 2015-2019
- Market Size of Deproteinized Calf Blood Extractives by regions in China 2015-2019
- Market Share of major manufacturers of Deproteinized Calf Blood Extractives in China 2015-2019
- Prices of major manufacturers of Deproteinized Calf Blood Extractives in China 2019-2020
- Forecast on the Chinese Deproteinized Calf Blood Extractives market 2020-2024
Table of Contents
1 Relevant Concept of Deproteinized Calf Blood Extractives
1.1 Indications
1.2 Development History of Deproteinized Calf Blood Extractives in China
1.3 Governmental Approval of Deproteinized Calf Blood Extractives in China
2 Overview of Chinese Deproteinized Calf Blood Extractives Market, 2015-2019
2.1 Sales Value of Deproteinized Calf Blood Extractives in China
2.1.1 Overall Sales Value of Deproteinized Calf Blood Extractives in China
2.1.2 Sales Value in Different Regions of China
2.2 Sales Volume of Deproteinized Calf Blood Extractives in China
2.2.1 Overall Sales Volume of Deproteinized Calf Blood Extractives in China
2.2.2 Sales Volume in Different Regions of China
2.3 Market Shares of Deproteinized Calf Blood Extractives by Different Dosage Forms in China
2.3.1 Injections
2.3.2 Gels
2.3.3 Eye Drops
3 Analysis on Major Deproteinized Calf Blood Extractives Manufacturers in China, 2015-2020
3.1 Market Competition
3.1.1 Market Shares by Sales Value
3. 1.2 Market Shares by Sales Volume
3.2 Shenyang Xingqi Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Shenyang Xingqi Pharmaceutical Co., Ltd.‘s Deproteinized Calf Blood Extractives
3.3 Harbin Sanctity Pharmaceutical Co., Ltd.
3.4 Jilin Connell Pharmaceutical Co., Ltd.
3.5 Wuhan Humanwell Pharmaceutical Co., Ltd.
3.6 Heilongjiang Jiangshi Pharmaceutical Co., Ltd.
3.7 Nycomed
3.8 Zhaoke Pharmaceutical (Hefei) Co. Ltd.
4 Prices of Deproteinized Calf Blood Extractives in China, 2019-2020
4.1 Average Prices of Deproteinized Calf Blood Extractives in China
4.1.1 Average Price of Deproteinized Calf Blood Extractives in China
4.1.2 Average Price of Deproteinized Calf Blood Extractives in Different Regions of China
4.2 Prices of Major Manufacturers’ Deproteinized Calf Blood Extractives in China
4.2.1 Prices of Shenyang Xingqi Pharmaceutical Co., Ltd.’s Deproteinized Calf Blood Extractives
4.2.2 Prices of Harbin Sanctity Pharmaceutical Co., Ltd.’s Deproteinized Calf Blood Extractives
4.2.3 Prices of Jilin Connell Pharmaceutical Co., Ltd.’s Deproteinized Calf Blood Extractives
4.2.4 Prices of Wuhan Humanwell Pharmaceutical Co., Ltd.’s Deproteinized Calf Blood Extractives
4.2.5 Prices of Heilongjiang Jiangshi Pharmaceutical Co., Ltd.’s Deproteinized Calf Blood Extractives
5 Prospects of Chinese Deproteinized Calf Blood Extractives Market, 2020-2024
5.1 Factors Influencing Deproteinized Calf Blood Extractives Development in China
5.1.1 Driving Forces and Market Opportunities
5.1.2 Threats and Challenges
5.2 Forecast on Market Size of Deproteinized Calf Blood Extractives in China 2020-2024
Selected Charts
Chart Patents of Deproteinized Calf Blood Extractives in China
Chart Governmental Approval of Deproteinized Calf Blood Extractives in China
Chart Sales of Deproteinized Calf Blood Extractives in China
Chart Sales Value of Deproteinized Calf Blood Extractives in China, 2015-2019
Chart Sales Value of Deproteinized Calf Blood Extractives in Parts of China, 2015-2019
Chart Sales Volume of Deproteinized Calf Blood Extractives in China, 2015-2019
Chart Sales Volume of Deproteinized Calf Blood Extractives in Parts of China, 2015-2019
Chart Market Shares of Top5 Deproteinized Calf Blood Extractives Manufacturers by Sales Value, 2015-2019
Chart Market Share and Sales Value of Shenyang Xingqi Pharmaceutical Co., Ltd.’s Deproteinized Calf Blood Extractives in China, 2015-2019
Chart Market Share and Sales Value of Heilongjiang Jiangshi’s Deproteinized Calf Blood Extractives in China, 2015-2019
Chart Market Shares of Top 5 Deproteinized Calf Blood Extractives Manufacturers by Sales Volume, 2015-2019
Chart Sales Value and Market Share of Deproteinized Calf Blood Extractives Injections, 2015-2019
Chart Sales Value and Market Share of Deproteinized Calf Blood Extractives Gels, 2015-2019
Chart Sales Value and Market Share of Deproteinized Calf Blood Extractives Eye Drops, 2015-2019
Chart Prices of Harbin Sanctity’s Deproteinized Calf Blood Extractives by regions of China, 2019-2020
Chart Prices of Heilongjiang Jiangshi’s Deproteinized Calf Blood Extractives by regions of China, 2019-2020
Chart Prices of Jilin Connell’s Deproteinized Calf Blood Extractives by regions of China, 2019-2020
Chart Forecast on Sales of Deproteinized Calf Blood Extractives in China, 2020-2024
Samples
LOADING...
Companies Mentioned
- Harbin Sanctity Pharmaceutical Co., Ltd.
- Heilongjiang Jiangshi Pharmaceutical Co., Ltd.
- Jilin Connell Pharmaceutical Co., Ltd.
- Nycomed
- Shenyang Xingqi Pharmaceutical Co., Ltd.
- Wuhan Humanwell Pharmaceutical Co., Ltd.
- Zhaoke Pharmaceutical (Hefei) Co. Ltd.
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
